Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL-007 plus tenofovir disoproxil fumarate in HBeAg-positive chronic hepatitis B
CTR20190904Phase 2Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QL-007 in Chronic Hepatitis B (CHB), sponsored by Qilu Pharmaceutical. Started Sep 2019; status: completed.
02
Drugs
QL-007
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20190904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190904.